Blueprint Medicines Market Cap

Blueprint Medicines has a market cap or net worth of €7.16 billion as of June 13, 2025. Its market cap has increased by 20.93% in one year.

Market Cap

7.16B

Enterprise Value

7.00B

Revenue

520.07M

Ranking

n/a

PE Ratio

n/a

Stock Price

€109.00

Market Cap Chart

Since April 30, 2015, Blueprint Medicines's market cap has increased from 435.41M to 7.16B, an increase of 1,545.17%. That is a compound annual growth rate of 31.88%.

Market Cap History

Date	Market Cap	% Change
Jun 10, 2025	7.25B	35.42%
Dec 31, 2024	5.35B	5.50%
Dec 29, 2023	5.07B	106.83%
Dec 30, 2022	2.45B	-55.74%
Dec 31, 2021	5.54B	8.45%
Dec 31, 2020	5.11B	45.47%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
UniCredit	88.76B
Intesa Sanpaolo	86.93B
Enel SpA	81.49B
Ferrari	73.60B
Assicurazioni Generali	47.26B
Eni S.p.A.	40.68B
Leonardo S.p.a.	27.90B
Stellantis	25.29B

Market Cap Rankings